ES2545639T3 - Pectato liasas, ácidos nucleicos que las codifican y métodos para su preparación y uso - Google Patents

Pectato liasas, ácidos nucleicos que las codifican y métodos para su preparación y uso Download PDF

Info

Publication number
ES2545639T3
ES2545639T3 ES04758802.5T ES04758802T ES2545639T3 ES 2545639 T3 ES2545639 T3 ES 2545639T3 ES 04758802 T ES04758802 T ES 04758802T ES 2545639 T3 ES2545639 T3 ES 2545639T3
Authority
ES
Spain
Prior art keywords
nucleic acid
seq
sequence
encodes
pectate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04758802.5T
Other languages
English (en)
Inventor
Janne Kerovuo
Arne Solbak
Kevin Gray
Ryan Mccann
Shalaka Purohit
Joel Gerendash
Giselle Janssen
Samun Dahod
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Enzymes LLC
Original Assignee
BASF Enzymes LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Enzymes LLC filed Critical BASF Enzymes LLC
Application granted granted Critical
Publication of ES2545639T3 publication Critical patent/ES2545639T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01067Galacturan 1,4-alpha-galacturonidase (3.2.1.67)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • C12N15/8246Non-starch polysaccharides, e.g. cellulose, fructans, levans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8282Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01015Polygalacturonase (3.2.1.15)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y402/00Carbon-oxygen lyases (4.2)
    • C12Y402/02Carbon-oxygen lyases (4.2) acting on polysaccharides (4.2.2)
    • C12Y402/02002Pectate lyase (4.2.2.2)

Abstract

Un ácido nucleico aislado, sintético, o recombinante que comprende (a) una secuencia de ácidos nucleicos que tiene una identidad de secuencia de al menos un 90 %, 91 %, 92 %, 93 %, 94 %, 95 %, 96 %, 97 %, 98 %, 99 %, o superior o que es idéntica en un 100 % a la SEC ID Nº: 77, sobre una región de al menos 950, 1000, 1050, 1100, 1150 o más restos, o la longitud completa de un gen o de un transcrito, en la que el ácido nucleico codifica al menos un polipéptido que tiene una actividad de pectato liasa; (b) una secuencia de ácidos nucleicos que comprende una secuencia como se establece en la SEC ID Nº: 77; (c) una secuencia de ácidos nucleicos que codifica un polipéptido que tiene una secuencia como se establece en las SEC ID Nº: 78, SEC ID Nº: 132 o SEC ID Nº: 134; (d) una secuencia que se hibrida en condiciones rigurosas con un ácido nucleico que comprende la SEC ID Nº: 77, SEC ID Nº: 131 o SEC ID Nº: 133, en la que el ácido nucleico codifica un polipéptido que tiene una actividad de pectato liasa, en la que las condiciones rigurosas incluyen una etapa de lavado que comprende un lavado en 0,2X SSC a una temperatura de aproximadamente 65 ºC durante aproximadamente 15 minutos; (e) el ácido nucleico de (a), (b), (c) o (d) que codifica un pectato liasa pero que carece de una secuencia señal, un dominio prepro, o una combinación de los mismos; (f) el ácido nucleico de (a), (b), (c), (d) o (e) que codifica un pectato liasa pero que también tiene una secuencia heteróloga; o (g) una secuencia complementaria con (a), (b), (c), (d), (e), o (f).

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19
imagen20
imagen21
imagen22
imagen23
imagen24
imagen25
imagen26
imagen27
imagen28
imagen29
imagen30
imagen31
imagen32
imagen33
imagen34
imagen35
imagen36
imagen37
imagen38
imagen39
imagen40
imagen41
imagen42
imagen43
imagen44
imagen45
imagen46
imagen47
imagen48
imagen49
imagen50
imagen51
imagen52
imagen53
imagen54
imagen55
imagen56
imagen57
imagen58
imagen59
imagen60
imagen61
imagen62
imagen63
imagen64
imagen65
imagen66
imagen67
imagen68
imagen69
imagen70
imagen71
imagen72
ejemplo, la formulación puede comprender una enzima de la invención en una cantidad entre aproximadamente 1000 u/ml y 10.000 u/ml.
Los estudios de solubilidad con producto liofilizado (SEC ID Nº: 134) resuspendido en agua indicaban que la
5 solubilidad de la enzima puede ser tan elevada como 25000 u/ml a 4 ºC. Por lo tanto, en un aspecto, la invención proporciona formulaciones que tienen un nivel tan elevado como aproximadamente 25000 u/ml, o superior. En un aspecto la invención proporciona formulaciones que comprenden una enzima de la invención en una cantidad entre aproximadamente 100 u/ml and 25000 u/ml, 30000 u/ml, 35000 u/ml o 40000 u/ml, o superior.
10 Diseño de la formulación:
La invención proporciona formulaciones que comprenden al menos una enzima de la invención, y, en aspectos alternativos, comprende adicionalmente cualquier aditivo o aditivos. Las formulaciones de la invención se pueden basar en aditivos conocidos en otras formulaciones enzimáticas, por ejemplo, análogas. Por ejemplo, las
15 formulaciones de la invención pueden comprender los aditivos y/o condiciones que se exponen en las Tablas 3, 4, 5 y 6, que siguen a continuación, o cualquier variación de las mismas. Por ejemplo, las formulaciones de la invención pueden comprender glicerol, sacarosa, cloruro sódico, dextrina, propilenglicol, sorbitol, sulfato sódico o TRIS, o un equivalente.
20 En un aspecto, una formulación de la invención puede ser una formulación basada en agua, o, una formulación basada en aceite.
Se realizaron dos fases de estudios de estabilidad de la formulación; estos estudios usaron la enzima a modo de ejemplo de la SEC ID Nº: 134.
25 Estudio de estabilidad acelerada a 37 ºC
Nota: se trata de formulaciones basadas en tampón.
30 • Identificar sistemáticamente diversos aditivos
Someter a ensayo diferentes valores de pH
Formulaciones a aproximadamente 2000 u/ml.
La SEC ID Nº: 134 fue la enzima a modo de ejemplo sometida a ensayo
35 Tabla 3 (SN = número de muestra)
SN
pH Glicerol Sacarosa Cloruro sódico Dextrina Propilen glicol sorbitol Sulfato sódico Conc. Eficaz de TRIS
1
5 40 mM
2
6 40 mM
3
7 40 mM
4
8 40 mM
5
7,5 35 % 20 mM
6
7,5 50 % 20 mM
7
7,5 35 % 20 mM
8
7,5 20 % 20 mM
9
7,5 10 % 20 mM
10
7,5 30 % 20 mM
11
7,5 100 mM 20 mM
12
7,5 35 % 20 mM
13
5,5 35 % 40 mM
14
5,5 50 % 40 mM
Formulaciones con el mayor rendimiento (usando la SEC ID Nº: 134 como una enzima a modo de ejemplo de la invención) basadas en el aspecto físico y en la retención de actividad superior a un 80 %:
74
imagen73
imagen74

Claims (1)

  1. imagen1
    imagen2
    imagen3
    imagen4
ES04758802.5T 2003-04-04 2004-04-02 Pectato liasas, ácidos nucleicos que las codifican y métodos para su preparación y uso Expired - Lifetime ES2545639T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US46084203P 2003-04-04 2003-04-04
US460842P 2003-04-04
US48479803P 2003-07-03 2003-07-03
US484798P 2003-07-03
PCT/US2004/010229 WO2004090099A2 (en) 2003-04-04 2004-04-02 Pectate lyases, nucleic acids encoding them and methods for making and using them

Publications (1)

Publication Number Publication Date
ES2545639T3 true ES2545639T3 (es) 2015-09-14

Family

ID=33162245

Family Applications (2)

Application Number Title Priority Date Filing Date
ES04758802.5T Expired - Lifetime ES2545639T3 (es) 2003-04-04 2004-04-02 Pectato liasas, ácidos nucleicos que las codifican y métodos para su preparación y uso
ES10180846.7T Expired - Lifetime ES2598037T3 (es) 2003-04-04 2004-04-02 Pectato liasas, ácidos nucleicos que las codifican y métodos para su preparación y uso

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES10180846.7T Expired - Lifetime ES2598037T3 (es) 2003-04-04 2004-04-02 Pectato liasas, ácidos nucleicos que las codifican y métodos para su preparación y uso

Country Status (9)

Country Link
US (2) US7592434B2 (es)
EP (2) EP1613733B1 (es)
CA (1) CA2521402C (es)
DK (2) DK2341136T3 (es)
ES (2) ES2545639T3 (es)
HU (1) HUE030493T2 (es)
MX (1) MXPA05010681A (es)
PL (2) PL2341136T3 (es)
WO (1) WO2004090099A2 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7645358B2 (en) * 2002-03-25 2010-01-12 Council Of Scientific And Industrial Research Process for biological deinking of office waste paper
US7685737B2 (en) 2004-07-19 2010-03-30 Earthrenew, Inc. Process and system for drying and heat treating materials
US7024800B2 (en) 2004-07-19 2006-04-11 Earthrenew, Inc. Process and system for drying and heat treating materials
US7610692B2 (en) 2006-01-18 2009-11-03 Earthrenew, Inc. Systems for prevention of HAP emissions and for efficient drying/dehydration processes
US20100029538A1 (en) 2006-04-14 2010-02-04 Anna-Liisa Auterinen One-Step Treatment of Textiles
WO2008138109A1 (en) * 2007-05-11 2008-11-20 National Research Council Of Canada Pectate lyases with increased thermostability and/or enzymatic activity
WO2010033823A2 (en) 2008-09-18 2010-03-25 University Of Georgia Research Foundation, Inc. Methods and compositions for degrading pectin
US8337978B2 (en) 2010-08-18 2012-12-25 Hewlett-Packard Development Company, L.P. Recording material containing nonionic surfactants
US8764894B2 (en) 2010-10-29 2014-07-01 Hewlett-Packard Development Company, L.P. Ink dispersion
US8884002B2 (en) 2010-12-01 2014-11-11 Fiberstar Bio-Ingredient Technologies, Inc. Viscosity control in compositions comprising plant fiber materials
US8628183B2 (en) 2011-02-15 2014-01-14 Hewlett-Packard Development Company, L.P. Ink coating composition
EP2543725A1 (en) 2011-07-08 2013-01-09 Biomay Ag Polysaccharide lyases
US8986977B2 (en) * 2011-12-30 2015-03-24 Alliance For Sustainable Energy, Llc Disruption of cell walls for enhanced lipid recovery
EP2834357B1 (en) 2012-04-04 2017-12-27 Life Technologies Corporation Tal-effector assembly platform, customized services, kits and assays
US9850512B2 (en) 2013-03-15 2017-12-26 The Research Foundation For The State University Of New York Hydrolysis of cellulosic fines in primary clarified sludge of paper mills and the addition of a surfactant to increase the yield
US9951363B2 (en) 2014-03-14 2018-04-24 The Research Foundation for the State University of New York College of Environmental Science and Forestry Enzymatic hydrolysis of old corrugated cardboard (OCC) fines from recycled linerboard mill waste rejects
WO2019051237A1 (en) 2017-09-08 2019-03-14 Life Technologies Corporation ENHANCED RECOMBINANT RECOMBINATION METHODS AND COMPOSITIONS THEREOF
JP2020534813A (ja) 2017-09-08 2020-12-03 ライフ テクノロジーズ コーポレイション 改良された相同組換えおよびその組成物のための方法
EP3784779A1 (en) 2018-04-26 2021-03-03 Basf Se Lipase enzymes
EP3788145A1 (en) 2018-05-03 2021-03-10 Basf Se Amylase enzymes
WO2019239357A1 (en) * 2018-06-12 2019-12-19 Buzzelet Development And Technologies Ltd Dental care cannabis device and use thereof
CN109023538B (zh) * 2018-07-12 2021-07-02 苏州麻朵纺织科技有限公司 精细化工业大麻的短流程零排水生产方法
CA3109795A1 (en) * 2018-08-17 2020-02-20 Cepheid Nucleic acid decontamination methods
EP3927809A1 (en) 2019-02-20 2021-12-29 Basf Se Industrial fermentation process for bacillus using defined medium and trace element feed
MX2021010110A (es) 2019-02-20 2021-09-21 Basf Se Proceso de fermentacion industrial para bacillus mediante el uso de medio definido y alimentacion de magnesio.
US20220170001A1 (en) 2019-03-25 2022-06-02 Basf Se Amylase Enzymes
WO2020193532A1 (en) 2019-03-25 2020-10-01 Basf Se Cleaning composition having amylase enzymes
US20220162576A1 (en) 2019-03-25 2022-05-26 Basf Se Amylase enzymes
US20220275355A1 (en) 2019-06-13 2022-09-01 Basf Se Method of Recovering a Protein from Fermentation Broth Using a Divalent Cation
MX2022000253A (es) 2019-07-05 2022-02-03 Basf Se Proceso de fermentacion industrial para celulas microbianas mediante el uso de un precultivo de alimentacion por lotes.
JP2022545465A (ja) 2019-08-22 2022-10-27 ビーエーエスエフ ソシエタス・ヨーロピア アミラーゼバリアント

Family Cites Families (149)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US5021246A (en) 1984-03-30 1991-06-04 Anheuser-Busch, Incorporated Step mashing process for producing low alcohol beer
US5087571A (en) 1984-06-22 1992-02-11 President And Fellows Of Harvard College Method for providing a cell culture from a transgenic non-human mammal
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DE3590766T (es) 1985-03-30 1987-04-23
US4962028A (en) 1986-07-09 1990-10-09 Dna Plant Technology Corporation Plant promotors
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5015580A (en) 1987-07-29 1991-05-14 Agracetus Particle-mediated transformation of soybean plants and lines
US5573933A (en) 1987-04-14 1996-11-12 Luminis Pty, Ltd. Transgenic pigs
US4788066A (en) 1987-12-14 1988-11-29 Grain Processing Corporation Preparation of low alcohol beer
US6054270A (en) 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5217879A (en) 1989-01-12 1993-06-08 Washington University Infectious Sindbis virus vectors
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5527681A (en) 1989-06-07 1996-06-18 Affymax Technologies N.V. Immobilized molecular synthesis of systematically substituted compounds
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5589583A (en) 1990-01-11 1996-12-31 Monsanto Company Plant promoter
EP0528881A4 (en) 1990-04-24 1993-05-26 Stratagene Methods for phenotype creation from multiple gene populations
US5326477A (en) 1990-05-07 1994-07-05 Bio-Sep, Inc. Process for digesting solid waste
EP0647268B1 (en) 1990-06-15 2004-03-03 Scios Inc. Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease
WO1992009696A1 (en) 1990-11-23 1992-06-11 Plant Genetic Systems, N.V. Process for transforming monocotyledonous plants
WO1992011272A1 (en) 1990-12-20 1992-07-09 Ixsys, Inc. Optimization of binding proteins
NL9100050A (nl) 1991-01-11 1992-08-03 Heineken Technische Beheer Bv Werkwijze voor het continu bereiden van wort.
US5405624A (en) 1991-02-14 1995-04-11 Bio-Technical Resources Process for producing a product with an intensified beer flavor
US6110700A (en) 1991-03-11 2000-08-29 The General Hospital Corporation PRAD1 cyclin and its cDNA
US5922854A (en) 1991-06-14 1999-07-13 Kumar; Ramesh Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids
CA2075135A1 (en) 1991-08-02 1993-02-03 David E. Ellis Particle-mediated transformation of gymnosperms
US5632957A (en) 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
EP0552728B1 (en) 1992-01-20 1999-06-09 Japan Tobacco Inc. Novel pectinase
JPH05236997A (ja) 1992-02-28 1993-09-17 Hitachi Ltd ポリヌクレオチド捕捉用チップ
CA2127807A1 (en) 1992-11-20 1994-06-09 John Maliyakal Transgenic cotton plants producing heterologous bioplastic
DE59305188D1 (de) 1992-12-31 1997-02-27 Metallgesellschaft Ag Verfahren zur herstellung von bier
US6021536A (en) * 1993-03-04 2000-02-08 Wasinger; Eric Mechanical desizing and abrading device
WO1995008914A1 (en) 1993-09-30 1995-04-06 Agracetus, Inc. Transgenic cotton plants producing heterologous peroxidase
US6045996A (en) 1993-10-26 2000-04-04 Affymetrix, Inc. Hybridization assays on oligonucleotide arrays
US5965452A (en) 1996-07-09 1999-10-12 Nanogen, Inc. Multiplexed active biologic array
US6468742B2 (en) 1993-11-01 2002-10-22 Nanogen, Inc. Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip
DK131193D0 (es) 1993-11-23 1993-11-23 Novo Nordisk As
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5639940A (en) 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
AU692841B2 (en) 1994-03-09 1998-06-18 Abbott Laboratories Transgenic animals producing oligosaccharides and glycoconjugates
WO1995024494A1 (en) 1994-03-09 1995-09-14 Abbott Laboratories Humanized milk
WO1995026397A1 (en) 1994-03-29 1995-10-05 Novo Nordisk A/S Alkaline bacillus amylase
US5750870A (en) 1994-06-17 1998-05-12 Agritope, Inc. Plant genetic transformation methods and transgenic plants
AU704022B2 (en) * 1994-06-17 1999-04-15 Genencor International, Inc. Cleaning compositions containing plant cell wall degrading enzymes and their use in cleaning methods
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5582681A (en) * 1994-06-29 1996-12-10 Kimberly-Clark Corporation Production of soft paper products from old newspaper
US5959171A (en) 1994-08-17 1999-09-28 Pharming B.V. Method for the production of biologically active polypeptides in a mammal's
CA2198451A1 (en) 1994-09-01 1996-03-07 Gurparkash Singh Transgenic animal expressing a familial form of human amyloid precursor protein
US5795737A (en) 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US6111166A (en) 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
US5880327A (en) 1994-09-21 1999-03-09 American National Red Cross Transgenic mammals expressing human coagulation factor VIII
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6187992B1 (en) 1994-12-05 2001-02-13 Merck & Co., Inc. Transgenic mouse having a disrupted amyloid precursor protein gene
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5633440A (en) 1994-12-20 1997-05-27 Dna Plant Technology Corporation P119 promoters and their uses
US6093562A (en) 1996-02-05 2000-07-25 Novo Nordisk A/S Amylase variants
US5959098A (en) 1996-04-17 1999-09-28 Affymetrix, Inc. Substrate preparation process
EP0831854A4 (en) 1995-06-06 2001-01-24 Isis Pharmaceuticals Inc OLIGONUCLEOTIDS WITH PHOSPHOROTHIOATE BINDINGS OF HIGH CHIRAL PURITY
AU6298896A (en) 1995-06-28 1997-01-30 Novo Nordisk A/S A cellulase with reduced mobility
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5985662A (en) 1995-07-13 1999-11-16 Isis Pharmaceuticals Inc. Antisense inhibition of hepatitis B virus replication
US6057103A (en) 1995-07-18 2000-05-02 Diversa Corporation Screening for novel bioactivities
US5958672A (en) 1995-07-18 1999-09-28 Diversa Corporation Protein activity screening of clones having DNA from uncultivated microorganisms
AU6513096A (en) 1995-07-19 1997-02-18 Novo Nordisk A/S Treatment of fabrics
US5721118A (en) 1995-10-31 1998-02-24 The Regents Of The University Of California, San Diego Mammalian artificial chromosomes and methods of using same
ES2216072T3 (es) 1995-11-15 2004-10-16 Novozymes A/S Proceso combinado de desencolado y "lavado a la piedra" de tejidos denim teñidos.
US6537776B1 (en) 1999-06-14 2003-03-25 Diversa Corporation Synthetic ligation reassembly in directed evolution
US5939250A (en) 1995-12-07 1999-08-17 Diversa Corporation Production of enzymes having desired activities by mutagenesis
US5965408A (en) 1996-07-09 1999-10-12 Diversa Corporation Method of DNA reassembly by interrupting synthesis
US6361974B1 (en) 1995-12-07 2002-03-26 Diversa Corporation Exonuclease-mediated nucleic acid reassembly in directed evolution
US5830696A (en) * 1996-12-05 1998-11-03 Diversa Corporation Directed evolution of thermophilic enzymes
US6022963A (en) 1995-12-15 2000-02-08 Affymetrix, Inc. Synthesis of oligonucleotide arrays using photocleavable protecting groups
AU1438397A (en) * 1996-01-29 1997-08-22 Novo Nordisk A/S Process for desizing cellulosic fabric
US6013440A (en) 1996-03-11 2000-01-11 Affymetrix, Inc. Nucleic acid affinity columns
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US6025155A (en) 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
DE19619219A1 (de) * 1996-05-13 1997-12-04 Hoechst Ag Enzym-Vorgranulat für Tierfuttermittel-Granulate
US6197070B1 (en) 1996-05-15 2001-03-06 The Procter & Gamble Company Detergent compositions comprising alpha combination of α-amylases for malodor stripping
US6057100A (en) 1996-06-07 2000-05-02 Eos Biotechnology, Inc. Oligonucleotide arrays
AU4067297A (en) * 1996-08-16 1998-03-06 International Paper Company Enzymatic freeness enhancement
US6326341B1 (en) 1996-09-11 2001-12-04 The Procter & Gamble Company Low foaming automatic dishwashing compositions
AU4550997A (en) * 1996-10-11 1998-05-11 Novo Nordisk A/S Cellulose binding domains (cbds) for oral care products
DE69738047T2 (de) * 1996-12-04 2008-05-15 Novozymes North America, Inc. Alkalisches enzymatisches abkochen von baumwolltextilien
US6069122A (en) 1997-06-16 2000-05-30 The Procter & Gamble Company Dishwashing detergent compositions containing organic diamines for improved grease cleaning, sudsing, low temperature stability and dissolution
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
ATE334225T1 (de) 1997-01-17 2006-08-15 Maxygen Inc Evolution prokaryotischer ganzer zellen durch rekursive sequenzrekombination
DE19703364A1 (de) 1997-01-30 1998-08-06 Henkel Ecolab Gmbh & Co Ohg Pastenförmiges Wasch- und Reinigungsmittel
ATE418608T1 (de) 1997-03-18 2009-01-15 Novozymes As Methode zur herstellung einer bibliothek mittels dna-shuffling
JP2001515356A (ja) 1997-03-18 2001-09-18 ノボ ノルディスク アクティーゼルスカブ Dnaライブラリーの試験管内作製方法
US5948653A (en) 1997-03-21 1999-09-07 Pati; Sushma Sequence alterations using homologous recombination
US6153410A (en) 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
US6826296B2 (en) 1997-07-25 2004-11-30 Affymetrix, Inc. Method and system for providing a probe array chip design database
JP2001514906A (ja) 1997-08-15 2001-09-18 ハイセック,インコーポレーテッド 核酸種を検出または定量するための方法および組成物
PT1012564E (pt) 1997-09-11 2003-08-29 Bioventures Inc Metodo de producao de arranjos de alta densidade
US6465178B2 (en) 1997-09-30 2002-10-15 Surmodics, Inc. Target molecule attachment to surfaces
WO1999021979A1 (en) 1997-10-28 1999-05-06 Maxygen, Inc. Human papillomavirus vectors
CA2845178A1 (en) 1997-10-30 1999-05-14 Novozymes A/S .alpha.-amylase mutants
EP1030861A4 (en) 1997-10-31 2001-09-05 Maxygen Inc MODIFICATION OF VIRAL TROPISM AND THE DIVERSITY OF HOST SPECIES BY RECOMBINATION OF THE VIRAL GENOME
ATE234913T1 (de) 1997-11-10 2003-04-15 Procter & Gamble Verfahren zur herstellung einer waschmitteltablette
EP0921189B1 (en) 1997-11-14 2005-01-12 Sankyo Company Limited Transgenic animal allergy models and methods for their use
US6165769A (en) * 1997-11-24 2000-12-26 Novo Nordisk A/S Pectin degrading enzymes from Bacillus licheniformis
US6187580B1 (en) * 1997-11-24 2001-02-13 Novo Nordisk A/S Pectate lyases
US6258590B1 (en) * 1998-11-02 2001-07-10 Novozymes A/S Biopreparation of textiles at high temperatures
DK2270234T3 (da) 1997-12-08 2013-06-03 California Inst Of Techn Fremgangsmåde til fremstilling af polynukleotid- og polypeptidsekvenser
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
CA2320960A1 (en) 1998-02-11 1999-08-19 Maxygen, Inc. Optimization of immunomodulatory properties of genetic vaccines
AU3289199A (en) 1998-02-11 1999-08-30 Maxygen, Inc. Antigen library immunization
DE69933369D1 (en) 1998-04-03 2006-11-09 Compound Therapeutics Inc Adressierbare protein arrays
US6156952A (en) 1998-04-09 2000-12-05 Constituent Institution Of The University Of Maryland System HIV transgenic animals and uses therefor
WO1999057360A1 (en) 1998-05-01 1999-11-11 Novo Nordisk A/S Enhancers such as n-hydroxyacetanilide
US6048695A (en) 1998-05-04 2000-04-11 Baylor College Of Medicine Chemically modified nucleic acids and methods for coupling nucleic acids to solid support
DE19824705A1 (de) 1998-06-03 1999-12-09 Henkel Kgaa Amylase und Protease enthaltende Wasch- und Reinigungsmittel
AU761570B2 (en) 1998-06-29 2003-06-05 Bristol-Myers Squibb Company Methods for generating highly diverse libraries
JP4335995B2 (ja) 1998-07-22 2009-09-30 昭 神谷 環境保全型粒状洗浄用組成物
FR2782323B1 (fr) 1998-08-12 2002-01-11 Proteus Procede de production in vitro de sequences polynucleotidiques recombinees, banques de sequences et sequences ainsi obtenues
US5980581A (en) 1998-09-08 1999-11-09 The Virkler Company Process for desizing and cleaning woven fabrics and garments
BR9913793A (pt) 1998-09-17 2001-10-16 Novo Nordisk Biochem Inc Métodos para remover a tinta e descolorir um papel impresso, para a produção de papel reciclado, e, polpa
US6277628B1 (en) 1998-10-02 2001-08-21 Incyte Genomics, Inc. Linear microarrays
US6277489B1 (en) 1998-12-04 2001-08-21 The Regents Of The University Of California Support for high performance affinity chromatography and other uses
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6024766A (en) 1999-01-27 2000-02-15 Wasinger; Eric M. Process for enzymatic desizing of garments and enzyme deactivation
US6399351B1 (en) * 1999-03-16 2002-06-04 Novozymes A/S Pectate lyases
US6511824B1 (en) 1999-03-17 2003-01-28 Exelixis, Inc. Nucleic acids and polypeptides of invertebrate TWIK channels and methods of use
US6309871B1 (en) 1999-03-31 2001-10-30 Novozymes A/S Polypeptides having alkaline α-amylase activity
US6221653B1 (en) 1999-04-27 2001-04-24 Agilent Technologies, Inc. Method of performing array-based hybridization assays using thermal inkjet deposition of sample fluids
US20100293669A2 (en) * 1999-05-06 2010-11-18 Jingdong Liu Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
US6162260A (en) * 1999-05-24 2000-12-19 Novo Nordisk Biochem North America, Inc. Single-bath biopreparation and dyeing of textiles
US6653151B2 (en) 1999-07-30 2003-11-25 Large Scale Proteomics Corporation Dry deposition of materials for microarrays using matrix displacement
DE69933574D1 (de) * 1999-08-06 2006-11-23 Toru Akazawa Verfahren zur behandlung von sojabohnen unter enzymverwendung, auf diese weise erhaltene sojabohnen sowie diese enthaltende lebensmittel
US20010008765A1 (en) 1999-12-06 2001-07-19 Fuji Photo Film Co., Ltd. DNA chip and reactive solid carrier
US6531644B1 (en) 2000-01-14 2003-03-11 Exelixis, Inc. Methods for identifying anti-cancer drug targets
WO2001079440A2 (en) * 2000-04-13 2001-10-25 Novozymes A/S Extracellular expression of pectate lyase using bacillus or escherichia coli
US6515109B1 (en) 2000-10-12 2003-02-04 Exelixis, Inc. Human ECT2 polypeptide
US6309872B1 (en) 2000-11-01 2001-10-30 Novozymes Biotech, Inc Polypeptides having glucoamylase activity and nucleic acids encoding same
US6576083B2 (en) 2001-04-05 2003-06-10 Novozymes A/S Deinking of waste paper
EP1389228B1 (en) 2001-05-14 2009-03-11 Novozymes A/S Detergent compositions comprising bacillus subtilis pectate lyases
CA2450709A1 (en) 2001-06-29 2003-01-09 Novozymes North America, Inc. Preparation of cellulosic materials
CN1253627C (zh) 2001-06-29 2006-04-26 诺维信北美公司 纤维素质的单浴制备
US9409174B2 (en) 2013-06-21 2016-08-09 Bio-Rad Laboratories, Inc. Microfluidic system with fluid pickups

Also Published As

Publication number Publication date
US20060210971A1 (en) 2006-09-21
HUE030493T2 (en) 2017-05-29
EP1613733A4 (en) 2007-04-18
MXPA05010681A (es) 2005-12-15
US8067222B2 (en) 2011-11-29
WO2004090099A2 (en) 2004-10-21
EP2341136B1 (en) 2016-06-08
US20100021988A1 (en) 2010-01-28
WO2004090099A3 (en) 2006-03-16
DK1613733T3 (en) 2015-08-31
EP1613733B1 (en) 2015-06-03
PL1613733T3 (pl) 2015-11-30
CA2521402C (en) 2015-01-13
DK2341136T3 (en) 2016-09-12
ES2598037T3 (es) 2017-01-24
US7592434B2 (en) 2009-09-22
CA2521402A1 (en) 2004-10-21
EP1613733A2 (en) 2006-01-11
EP2341136A1 (en) 2011-07-06
PL2341136T3 (pl) 2016-12-30

Similar Documents

Publication Publication Date Title
ES2545639T3 (es) Pectato liasas, ácidos nucleicos que las codifican y métodos para su preparación y uso
Hebda et al. Mast cell and myofibroblast in wound healing
ES2190503T3 (es) Heterociclos de 5 anillos en calidad de inhibidores de la adhesion de leucocitos y antagonistas de vla-4.
AR023229A1 (es) Polipéptidos mutantes, y su uso en composiciones detergentes.
AR036160A1 (es) Regulacion de las vias metabolicas lipidicas en las plantas, mediante transgenesis con sentido o antisentido de factores de transcripcion hap2, hap5 y hap3/lec1
WO2002016547A3 (en) Subtilase enzymes
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
AR036883A1 (es) Limpiadores para superficies duras que contienen tensioactivos de copolimero de bloque de oxido de etileno y oxido de propileno
BR9507552A (pt) Extrato de cartilagem de tubarão tendo uma atividade angiogênica e um efeito sobre regressão de tumor e processo para a sua preparação
YU64701A (sh) Jedinjenja upotrebljiva kao anti-inflamatorna sredstva
ES2073532T3 (es) Copolimeros de bajo peso molecular, solubles en agua, procedimientos para su preparacion, y composiciones detergentes que contienen dichos copolimeros.
ES2172789T3 (es) Composiciones de limpieza alcalinas para superficies duras.
AR063263A1 (es) Agentes tensioactivos reconstituidos
BR0114030A (pt) Método para preparação de células dendrìticas maduras, crioconservadas, prontas para uso, introduzidas ou não com antìgenos
PE114699A1 (es) Composicion detergente para superficies duras que comprende un polimero hidrofilo a nivel muy bajo que atenua el esfuerzo cortante
EA200100732A1 (ru) Противовоспалительные и иммуносупрессорные соединения, ингибирующие клеточную адгезию
DK1165759T3 (da) Polypeptider, der har forgrenende enzymaktivitet, og nukleinsyrer, der koder for samme
Suzuki et al. Sequence analysis of vasotocin cDNAs of the lamprey, Lampetra japonica, and the hagfish, Eptatretus burgeri: evolution of cyclostome vasotocin precursors
CO2020015707A2 (es) Casetes de expresión de α-glucosidasa de ácido optimizado con codón y métodos de uso del mismo
Aisien et al. Anuran parasites from three biotopes in Rivers State, Nigeria
AR008106A1 (es) Procedimiento para producir reina y derivados de reina, derivados obtenidos, y composicion farmaceutica y preparacion cosmetica que loscontienen
BR0307024A (pt) Processo para a remoção de sujeira gordurosa de uma superfìcie dura, composição lìquida para limpeza, e, uso de um antioxidante removedor de radical e de peróxido de hidrogênio em uma composição lìquida para limpeza
ES2059321T3 (es) Heparinas, fracciones y fragmentos de heparinas libres de edta, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AR074941A1 (es) Plantas transplastomicas exentas de marcador de seleccion
CO5040175A1 (es) Composicion de limpieza para superficies duras que contienen un diester de glicol polialcoxileno